Oral Hyaluronic Acid: What Trials Show (Not Like HA Injections)
Educational overview — not medical advice. This page covers ORAL (ingested) hyaluronic acid supplements only, a separate product from HA dermal filler injections and topical HA skincare serums; oral evidence does not transfer to either. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
If you searched "hyaluronic acid" expecting dermal fillers or a skincare serum, this page is not that. Oral HA capsules, injected HA fillers, and topical HA serums are three different products with three different evidence bases — nothing here about swallowed HA implies anything about how injections or serums perform. On the oral evidence itself: the biggest, most-replicated pocket is skin hydration and wrinkle depth, where four small 8-12–week trials at 120mg/day found modest improvements — but most of that evidence comes from authors employed by Kewpie Corporation, the manufacturer of the Hyabest HA ingredient used in the trials. Joint/osteoarthritis evidence is thinner and uses inconsistent doses of different ingredients (200mg plain HA vs 80mg of a different branded ingredient across the two trials). And the mechanism by which oral HA might reach the skin at all has only been tested in animals, never in humans.
As an Amazon Associate we earn from qualifying purchases. On best hyaluronic acid, products are ranked by trial-dose match and trial-matched ingredient first, price second — not by commissions.
Start here
What oral HA is, and the three evidence threads
Hyaluronic acid (HA) is a large polysaccharide the body already makes and uses to hold water in skin, joints, and connective tissue — it's not an essential nutrient, so there's no deficiency state, no RDA, and no government-set upper limit; any claimed benefit of supplementing has to stand on its own trial evidence, the way it does for a non-essential compound rather than a vitamin correcting a shortfall. Twelve verified human and animal studies make up the oral-HA evidence base, splitting into three threads. First, skin hydration and wrinkle depth is the largest and most-replicated pocket: Oe 2017 (n=60, 12 weeks) and Hsu 2021 (n=40, 12 weeks) are the two strongest, both double-blind and placebo-controlled at 120mg/day, both finding measurable improvement in wrinkle measures and skin water content from around week 8. But read the funding line every time: most authors on both trials are employed by Kewpie Corporation, which also makes the Hyabest HA ingredient the trials used — see the full breakdown. Second, knee osteoarthritis evidence is thinner and dose-inconsistent: Tashiro 2012 tested 200mg/day of plain HA for 12 months and found age-dependent symptom improvement, while Nelson 2015 tested only 80mg/day of a completely different branded ingredient (Oralvisc/Hyal-Joint DS) for 3 months. Two trials, two ingredients, two doses — not one settled "joint dose." Third, a single small pilot trial (Kim 2019) tested oral HA as an add-on to topical drops for dry eye, not as standalone evidence.
Does it work? (the honest short version)
For skin, modestly and with a funding caveat that has to be stated every time: hydration and wrinkle-depth measures improve in small trials at 120mg/day over 8-12 weeks, and the finding replicates across four separate small studies — but three of the four strongest trials share Kewpie-affiliated co-authors, the maker of the Hyabest ingredient tested. A broader 2022 meta-analysis (Sun 2022) found a significant pooled hydration effect across several skin-moisturizing supplements including HA — it is not an HA-exclusive review, and shouldn't be cited as one. For joints, the evidence is real but genuinely modest and does not add up to a proven osteoarthritis treatment: Tashiro's benefit faded in patients over 70, and Nelson's positive trial used a different ingredient at a lower dose entirely. Nothing here is a substitute for medical OA management, and nothing here is evidence for HA injections into the joint, which are a different procedure with a different evidence base.
The one-line takeaway Oral HA capsules are not HA injections or skincare serums — different products, different evidence, and the distinction matters because "hyaluronic acid" as a search term is dominated by the other two. The oral skin-hydration signal is real, replicated across four small trials at 120mg/day, and mostly funded by the ingredient's own manufacturer (Kewpie). The joint evidence is thinner and uses inconsistent doses of different ingredients. And whether oral HA reaches the skin at all has only been tested in animals — see the absorption page. No anti-aging, cure, or "replaces HA injections" claim is supported by any of it. See best hyaluronic acid.
The buying problem
Because "hyaluronic acid supplement" actually covers three different product types, the milligram number on the front of a bottle can mean three different things. Plain sodium hyaluronate capsules (Jarrow, NOW, Nutricost) are chemically identical HA, but the specific branded product was never itself put through a trial — only the compound class was. Hyabest (Natural Factors) is the specific fermentation-derived ingredient that Oe 2017 and Hsu 2021 actually used, and comes from the same Kewpie research program that developed the ingredient behind Kawada 2014 — it has a higher total bottle price ($34.97) but is NOT more expensive per mg of HA; at 60 servings it's actually slightly cheaper per mg than the plain generics. And BioCell Collagen (Doctor's Best) bundles HA with collagen type II and chondroitin sulfate, where HA is a disclosed minority component (roughly 100mg within a 1000mg blend) — not the ingredient being dosed, and not a fair mg-for-mg price comparison against the plain products. The full ranking keeps these three categories honestly separated instead of comparing them as if interchangeable.
Safety
No serious adverse events have been reported across the RCTs in this evidence base, at doses from 80mg to 1g/day of combo products, over durations from 6 weeks up to Tashiro's 12-month OA trial — the longest human data point in this category. HA itself has a long history of use in food, cosmetics, and medicine, including injectable/medical contexts, which is a separate risk profile from oral supplementation. Two honest gaps: most human trial data is short-term (12 weeks or less, with Tashiro the notable 12-month exception), and no published dose-ranging safety study exists for oral HA the way there is for some other supplements, so there's no tested upper bound to cite. There's no dedicated pregnancy/breastfeeding trial data — default to clinician input because of the absence of data, not because of a specific harm signal.
On this page
Hyaluronic Acid Benefits: What Oral Trials Actually Show
Ready to buy? See the best hyaluronic acid ranked by cost per mg, with plain HA, Hyabest, and BioCell Collagen kept honestly separate →
Skin hydration and wrinkles: the strongest evidence, and it has its own page
This is the most-replicated finding in the oral-HA category: four small trials, including Oe 2017 (n=60, double-blind, placebo-controlled) and Hsu 2021 (n=40, double-blind, placebo-controlled), found modest improvements in skin hydration, elasticity, and wrinkle depth at 120mg/day over 8-12 weeks. The catch is funding: most of the authors on the two strongest trials are employed by Kewpie Corporation, which also manufactures the Hyabest HA ingredient those trials tested — a caveat worth repeating every time this finding gets cited. We've broken down all four trials, including which were blinded and which weren't, on the dedicated skin-hydration page.
Knee osteoarthritis: modest, from two trials that aren't the same intervention
Two small trials test oral HA for knee osteoarthritis, and they used different ingredients at different doses — read them separately, not as one collective "joint dose."
Tashiro 2012, PMID: 23226979 randomized 60 adults with knee osteoarthritis (Kellgren-Lawrence grade 2 or 3) to 200mg/day of plain hyaluronic acid or placebo for 12 months, while both groups also did daily quadriceps-strengthening exercise. Knee symptom scores (the Japanese Knee Osteoarthritis Measure, JKOM) improved over time in both groups; the improvement was described as more pronounced in the HA group, and that difference reached statistical significance against placebo at months 2 and 4 specifically in the subgroup of participants aged 70 or younger. The trial's own abstract does not report the difference as significant for the full 60-person sample, and doesn't report a significance figure at the 12-month endpoint or for the over-70 subgroup. That's a real but narrow finding — an age-subgroup result at two mid-study timepoints, not "oral HA fixes knee osteoarthritis."
Nelson 2015, PMID: 24899570 tested a different, branded ingredient — Oralvisc, a blend of hyaluronic acid with other glycosaminoglycans, at roughly 80mg/day — in 40 obese knee-osteoarthritis patients over 3 months. It found statistically significant improvements in pain and function scores (visual analog scale pain and WOMAC), alongside reductions in several inflammatory markers measured in blood and joint fluid. That's a different ingredient, a different dose, and a quarter of the duration of Tashiro's trial, so it isn't a replication of Tashiro's result — it's a separate positive finding for a different product.
Neither trial tested or has anything to say about an HA injection into the knee (viscosupplementation), a medical procedure a doctor performs directly on the joint. That's a completely different delivery route and evidence base from a capsule you swallow.
Dry eye: one small trial, and it wasn't oral HA alone
The dry-eye evidence is the thinnest of the three, and the trial design matters here: Kim 2019, PMID: 31662894 randomized 54 people with dry eye disease, but every participant used topical hyaluronic acid eye drops throughout the trial — the 24-person study group added an oral HA supplement on top of the drops, while the rest used the drops alone. So this tested oral HA as an add-on to topical treatment, not oral HA by itself against placebo.
In the group that got both, standard dry-eye measures improved over 3 months: the Ocular Surface Disease Index symptom score fell from 61.8 to 42.3 (p<0.001), tear break-up time rose to 4.7 seconds by 3 months (p<0.012), and corneal fluorescein staining — a marker of surface damage — dropped from 1.8 to 0.8 within the first month (p<0.001). The authors concluded the combination worked better than topical HA alone, but the abstract doesn't report the control group's own numbers for a direct side-by-side comparison. Read this as a preliminary signal for oral HA as an add-on to standard drops, not evidence that a capsule treats dry eye on its own.
Does oral HA even reach these tissues?
All three benefit threads above depend on oral HA surviving digestion and reaching skin, joint, or eye tissue in a functional amount — and that mechanism has never been directly tested in humans. Native hyaluronic acid is a large polysaccharide, with molecular weight that can run into the millions of Daltons, well outside the size range most nutrients are absorbed intact. The only evidence it crosses the gut wall and reaches tissue at all comes from two animal tracer studies in rats and dogs (Balogh 2008, Oe 2014) — see the full breakdown of what they found, and didn't establish, on the dedicated absorption page.
| Benefit | Trial dose & duration | What the trial found | Key caveat |
|---|---|---|---|
| Skin hydration & wrinkles | 120mg/day, 8–12 weeks (4 trials) | Modest improvement in hydration, elasticity, wrinkle depth | Most trials share Kewpie-affiliated authors — full breakdown → |
| Knee osteoarthritis (plain HA) | 200mg/day, 12 months (Tashiro 2012, n=60) | Symptom score significantly better than placebo at months 2 & 4, only in the ≤70 subgroup | Subgroup finding, not the full sample or the 12-month endpoint |
| Knee osteoarthritis (branded blend) | ~80mg/day, 3 months (Nelson 2015, n=40) | Significant improvement in pain and function scores | Different ingredient (Oralvisc) and dose than Tashiro — not the same product |
| Dry eye | 3 months, oral HA + topical drops (Kim 2019, n=24 study group) | Symptom score, tear break-up time, corneal staining all improved | Tested as add-on to topical drops, not oral HA alone |
Frequently asked questions
Is oral hyaluronic acid the same as HA injections or skincare serums?
No. Oral capsules, injected dermal fillers, and topical serums are three different products with three different evidence bases and risk profiles. Oral evidence never implies anything about the other two.
Does oral hyaluronic acid actually improve skin?
Modestly, in small 8-12 week trials at 120mg/day — but most of the evidence shares Kewpie Corporation-affiliated authors (the Hyabest ingredient maker), a funding caveat worth repeating every time.
Does oral hyaluronic acid help joint pain or osteoarthritis?
Modestly, in thin evidence. Two small trials used different ingredients at different doses (200mg plain HA vs 80mg of a branded ingredient) — not a proven OA treatment or a substitute for HA injections.
Does oral HA actually reach the skin?
Unresolved in humans. The only mechanism studies are animal tracer studies (rats/dogs) — plausible, not proven in people.
What are the best-evidenced benefits of oral hyaluronic acid?
Skin hydration and wrinkle depth have the clearest support: four small trials, most 8-12 weeks, found modest improvement at 120mg/day, though most of that evidence comes from authors employed by Kewpie Corporation, the manufacturer of the HA ingredient the strongest trials tested. Knee osteoarthritis has thinner support from two small trials that used different HA-containing ingredients at different doses — 200mg/day of plain HA for 12 months, or roughly 80mg/day of a branded blend for 3 months. Dry eye has only one small trial, and it tested oral HA as an add-on to topical HA eye drops, not on its own. None of this is HA injected into a joint or skin, which is a different product with a different evidence base.
Does oral hyaluronic acid help skin hydration and wrinkles?
Modestly, in small trials at 120mg/day over 8-12 weeks — this is the most-replicated benefit in the category, but most of the evidence shares authors employed by Kewpie Corporation, the maker of the Hyabest HA ingredient tested. See the full trial-by-trial breakdown, including which trials were blinded and which weren't, on our dedicated skin-hydration page.
Does oral hyaluronic acid help knee osteoarthritis?
Modestly, in two small trials that aren't directly comparable. Tashiro 2012 found 200mg/day of plain HA for 12 months significantly improved knee symptom scores versus placebo at months 2 and 4 — but only in the subgroup of participants aged 70 or younger, not reported as significant for the full 60-person sample. Nelson 2015 found a different branded ingredient (Oralvisc, an HA-containing glycosaminoglycan blend) at roughly 80mg/day improved pain and function over 3 months. Different ingredients, different doses — not one settled "joint dose," and not a substitute for an HA injection into the joint, which is an entirely different procedure.
Does oral hyaluronic acid help dry eyes?
There's one small trial, and it didn't test oral HA alone. Kim 2019 randomized 54 people with dry eye disease; everyone used topical HA eye drops, and the 24-person study group added an oral HA supplement on top. That group's symptom scores, tear break-up time, and corneal surface measures all improved significantly over 3 months. That's a preliminary signal for oral HA as an add-on to standard drops, not evidence that a capsule treats dry eye by itself.
Is oral hyaluronic acid the same as an HA knee injection?
No. HA injections (viscosupplementation) are a medical procedure where a doctor injects hyaluronic acid directly into an arthritic joint — a completely different delivery route, dose, and evidence base from a swallowed capsule. The oral-HA joint trials on this page (Tashiro 2012, Nelson 2015) tested capsules taken by mouth; neither tested nor implies anything about how injectable HA performs, and the reverse is also true.
Related guides
- Collagen — the other skin-and-joint structural-protein supplement, with its own type/dose distinctions
- Astaxanthin — another skin-focused antioxidant with real-but-narrow human evidence
- Glucosamine — the other joint-cartilage supplement, often stacked with chondroitin
- Omega-3 — a joint-inflammation-adjacent supplement with a much larger trial base
Sources
- Oe M, et al. "Oral hyaluronan relieves wrinkles: a double-blinded, placebo-controlled study over a 12-week period." Clin Cosmet Investig Dermatol. 2017. PMID: 28761365
- Hsu TF, et al. "Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study." Nutrients. 2021. PMID: 34203487
- Kawada C, et al. "Ingested hyaluronan moisturizes dry skin." Nutrition Journal. 2014. PMID: 25014997
- Sun Q, et al. "Effectiveness of Dietary Supplement for Skin Moisturizing in Healthy Adults: A Systematic Review and Meta-Analysis of RCTs." Front Nutr. 2022. PMID: 35719159
- Tashiro T, et al. "Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis." The Scientific World Journal. 2012. PMID: 23226979
- Nelson FR, et al. "The effects of an oral preparation containing hyaluronic acid (Oralvisc) on obese knee osteoarthritis patients." Rheumatol Int. 2015. PMID: 24899570
- Kim Y, et al. "Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease: A Pilot Study." J Ophthalmol. 2019. PMID: 31662894
- Balogh L, et al. "Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs." J Agric Food Chem. 2008. PMID: 18959406
- Oe M, et al. "Dietary hyaluronic acid migrates into the skin of rats." The Scientific World Journal. 2014. PMID: 25383371
- Full product dataset: /hyaluronic-acid/cost-by-brand.json (CC BY 4.0).